Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Spriet

Showing results (141-150 of 237) with videos related to

Pageof 24
Sort By:
The Pediatric Infectious Disease Journal|November 7, 2015
Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface AreaKim Vanstraelen, Anca Colita, Ana Maria Bica, et al.
Quality & Safety in Health Care|July 3, 2010
Pharmacist- versus physician-acquired medication history: a prospective study at the emergency departmentSabrina De Winter, Isabel Spriet, Christophe Indevuyst, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2015
Factors impacting unbound vancomycin concentrations in different patient populationsMatthijs Oyaert, Isabel Spriet, Karel Allegaert, et al.
BMC Infectious Diseases|December 6, 2025
Antimicrobial stewardship strategies for implementing the 2019 EUCAST "I" definitionEvelyne Van den Broucke, Charlotte Quintens, Willy E Peetermans, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature ReviewBeatrijs Mertens, Omar Elkayal, Erwin Dreesen, et al.
The Journal of Trauma and Acute Care Surgery|June 4, 2016
Augmented renal clearance in non-critically ill abdominal and trauma surgery patients is an underestimated phenomenon: A point prevalence studyPeter Declercq, Stefaan Nijs, André DʼHoore, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2021
Letermovir exposure in transplant patients with end-stage renal disease on renal replacement therapyNora Isberner, Ruth Van Daele, Hartwig Klinker, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
The Potential Role of Bacteriophages in the Treatment of Recalcitrant Chronic RhinosinusitisSaartje Uyttebroek, Jolien Onsea, Willem-Jan Metsemakers, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2024
Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation studyOmar Elkayal, Beatrijs Mertens, Joost Wauters, et al.
Clinical Pharmacokinetics|March 27, 2024
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of PosaconazoleAnouk M E Jansen, Kim Snijdelaar, Ron J Keizer, et al.
Pageof 24

Showing results (141-150 of 237) with videos related to

Sort By:
Pageof 24
The Pediatric Infectious Disease Journal|November 7, 2015
Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface AreaKim Vanstraelen, Anca Colita, Ana Maria Bica, et al.
Quality & Safety in Health Care|July 3, 2010
Pharmacist- versus physician-acquired medication history: a prospective study at the emergency departmentSabrina De Winter, Isabel Spriet, Christophe Indevuyst, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2015
Factors impacting unbound vancomycin concentrations in different patient populationsMatthijs Oyaert, Isabel Spriet, Karel Allegaert, et al.
BMC Infectious Diseases|December 6, 2025
Antimicrobial stewardship strategies for implementing the 2019 EUCAST "I" definitionEvelyne Van den Broucke, Charlotte Quintens, Willy E Peetermans, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature ReviewBeatrijs Mertens, Omar Elkayal, Erwin Dreesen, et al.
The Journal of Trauma and Acute Care Surgery|June 4, 2016
Augmented renal clearance in non-critically ill abdominal and trauma surgery patients is an underestimated phenomenon: A point prevalence studyPeter Declercq, Stefaan Nijs, André DʼHoore, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2021
Letermovir exposure in transplant patients with end-stage renal disease on renal replacement therapyNora Isberner, Ruth Van Daele, Hartwig Klinker, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
The Potential Role of Bacteriophages in the Treatment of Recalcitrant Chronic RhinosinusitisSaartje Uyttebroek, Jolien Onsea, Willem-Jan Metsemakers, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2024
Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation studyOmar Elkayal, Beatrijs Mertens, Joost Wauters, et al.
Clinical Pharmacokinetics|March 27, 2024
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of PosaconazoleAnouk M E Jansen, Kim Snijdelaar, Ron J Keizer, et al.
Pageof 24